Vivani Medical, Inc. will present at the Partnership Opportunities in Drug Delivery (PODD) event in Boston on October 29, 2024, and the ThinkEquity Conference in New York on October 30, 2024. CEO Dr. Adam Mendelsohn will discuss the company's innovative drug delivery systems, including its lead program, NPM-115, a six-month GLP-1 implant for chronic weight management. Vivani aims to address medication non-adherence, a significant issue affecting patient outcomes and healthcare costs.